Balance Sheet Dive: Altimmune Inc (ALT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $7.20 in the prior trading day, Altimmune Inc (NASDAQ: ALT) closed at $6.74, down -6.39%. In other words, the price has decreased by -$6.39 from its previous closing price. On the day, 3.45 million shares were traded. ALT stock price reached its highest trading level at $7.47 during the session, while it also had its lowest trading level at $6.71.

Ratios:

Our goal is to gain a better understanding of ALT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.55 and its Current Ratio is at 16.55. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On January 24, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $13.

Goldman Downgraded its Buy to Neutral on March 22, 2023, whereas the target price for the stock was revised from $20 to $6.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’23 when Drutz David bought 300 shares for $2.88 per share. The transaction valued at 862 led to the insider holds 29,785 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 510495680 and an Enterprise Value of 296408768. For the stock, the TTM Price-to-Sale (P/S) ratio is 1165.53 while its Price-to-Book (P/B) ratio in mrq is 2.76. Its current Enterprise Value per Revenue stands at 722.948 whereas that against EBITDA is -3.365.

Stock Price History:

The Beta on a monthly basis for ALT is 0.12, which has changed by 0.982353 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $14.84, while it has fallen to a 52-week low of $2.09. The 50-Day Moving Average of the stock is -5.02%, while the 200-Day Moving Average is calculated to be -2.84%.

Shares Statistics:

The stock has traded on average 3.59M shares per day over the past 3-months and 7604260 shares per day over the last 10 days, according to various share statistics. A total of 70.68M shares are outstanding, with a floating share count of 70.35M. Insiders hold about 0.78% of the company’s shares, while institutions hold 62.72% stake in the company. Shares short for ALT as of 1718323200 were 23143297 with a Short Ratio of 6.45, compared to 1715731200 on 23064510. Therefore, it implies a Short% of Shares Outstanding of 23143297 and a Short% of Float of 32.900003.

Most Popular